PLUS THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$16M
↑+146.1% +$10Mvs FY2024
Total Liabilities
$12M
↓-20.9% -$3Mvs FY2024
Equity
$4M
↑+144.7% +$13Mvs FY2024
Cash
$4M
↑+5500.0% +$4Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $16M | $7M |
| Current Assets | $15M | $5M |
| Cash | $4M | $76K |
| ST Investments | $4M | $4M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $7M | $2M |
| Non-Current Assets | $1M | $1M |
| PPE | $257K | $448K |
| Goodwill | $372K | $372K |
| Intangibles | $333K | $469K |
| Investments | $0 | $0 |
| Other Non-Current | $193K | $85K |
| Total Liab+Eq | $16M | $7M |
| Current Liab. | $12M | $16M |
| Accounts Payable | $3M | $9M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $9M | $6M |
| Non-Current Liab. | $15K | $31K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $15K | $31K |
| Equity | $4M | $-9M |
| Retained Earnings | $516M | $493M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · PSTV · Comparing FY2025 vs FY2024